MedTrace Logo

Prognostic Value of Biochemical Markers in Cerebrospinal Fluid for Functional Outcome of Spinal Cord Injured Patients

NCT01861808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-10-19

No results posted yet for this study

Summary

The project is aimed to develop predictive indices of spinal cord injury severity through the analysis of cerebrospinal fluid of patient collected during acute injury.

Conditions

  • Spinal Cord Injuries

Interventions

OTHER

Lumbar puncture

The only intervention is the lumbar puncture on the patients to obtain a Cerebrospinal Fluid sample

Sponsors & Collaborators

  • Azienda Usl di Bologna

    lead OTHER_GOV

Principal Investigators

  • Giovanni Gordini, MD · Azienda Unità Sanitaria Locale Bologna

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-24
Primary Completion
2016-09-01
Completion
2017-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01861808 on ClinicalTrials.gov